Fig. 5
From: Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients
Kaplan-Meier curves showing the probability of disease-free according to treatment options in patients having tumors with: a low and b high expression of CDX2; c low and d high expression of MUC2; and e absence and f presence of SOX2, respectively. The log-rank test was used to test for differences in survival between treatment and absence of treatment with adjuvant chemotherapy, while univariable Cox regression (Wald) was used to generate hazard ratios (HR) and 95% confidence intervals (CI), after adjustment for sex and tumor grade